The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Standard

The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation. / Hergel, Laura Louise Fosgrau; Kielsen, Katrine; Weischendorff, Sarah; Ifversen, Marianne; Kamari-Kany, Nakisa; Møller, Holger Jon; Rittig, Søren; Grønbæk, Henning; Müller, Klaus.

I: Bone Marrow Transplantation, Bind 58, 2023, s. 587–589.

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Harvard

Hergel, LLF, Kielsen, K, Weischendorff, S, Ifversen, M, Kamari-Kany, N, Møller, HJ, Rittig, S, Grønbæk, H & Müller, K 2023, 'The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation', Bone Marrow Transplantation, bind 58, s. 587–589. https://doi.org/10.1038/s41409-023-01927-3

APA

Hergel, L. L. F., Kielsen, K., Weischendorff, S., Ifversen, M., Kamari-Kany, N., Møller, H. J., Rittig, S., Grønbæk, H., & Müller, K. (2023). The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplantation, 58, 587–589. https://doi.org/10.1038/s41409-023-01927-3

Vancouver

Hergel LLF, Kielsen K, Weischendorff S, Ifversen M, Kamari-Kany N, Møller HJ o.a. The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2023;58:587–589. https://doi.org/10.1038/s41409-023-01927-3

Author

Hergel, Laura Louise Fosgrau ; Kielsen, Katrine ; Weischendorff, Sarah ; Ifversen, Marianne ; Kamari-Kany, Nakisa ; Møller, Holger Jon ; Rittig, Søren ; Grønbæk, Henning ; Müller, Klaus. / The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation. I: Bone Marrow Transplantation. 2023 ; Bind 58. s. 587–589.

Bibtex

@article{5bcd5e0af93d48d1aa8790a389763998,
title = "The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation",
author = "Hergel, {Laura Louise Fosgrau} and Katrine Kielsen and Sarah Weischendorff and Marianne Ifversen and Nakisa Kamari-Kany and M{\o}ller, {Holger Jon} and S{\o}ren Rittig and Henning Gr{\o}nb{\ae}k and Klaus M{\"u}ller",
note = "Funding Information: This study was supported by The Danish Cancer Society (R228-A13611). ",
year = "2023",
doi = "10.1038/s41409-023-01927-3",
language = "English",
volume = "58",
pages = "587–589",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation

AU - Hergel, Laura Louise Fosgrau

AU - Kielsen, Katrine

AU - Weischendorff, Sarah

AU - Ifversen, Marianne

AU - Kamari-Kany, Nakisa

AU - Møller, Holger Jon

AU - Rittig, Søren

AU - Grønbæk, Henning

AU - Müller, Klaus

N1 - Funding Information: This study was supported by The Danish Cancer Society (R228-A13611).

PY - 2023

Y1 - 2023

U2 - 10.1038/s41409-023-01927-3

DO - 10.1038/s41409-023-01927-3

M3 - Comment/debate

C2 - 36721043

AN - SCOPUS:85147108000

VL - 58

SP - 587

EP - 589

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -

ID: 335296089